Forging a position as an innovative player in
infectious disease vaccines and therapies

Home
About
Our Technology
Business Development
- Partner Network
- Licensing Strategy and Available Licenses
Investor Relations
Contact Us
- Corporate directory

BioDiem » » Opal acquisition of Formulytica – Capital raising

Opal acquisition of Formulytica – Capital raising May 6, 2021 • Category • Author Name

Opal acquisition of Formulytica – Capital raising

Latest News

2024 AGM CEO Presentation

December 3, 2024

2024 AGM CEO Presentation

Read More
2024 AGM Chairman’s Address

December 3, 2024

2024 AGM Chairman’s address

Read More

Join our email list!

Join our email distribution list to be updated with announcements.

© Copyright 2014 BioDiem

Privacy Policy
Terms and conditions